Skip to main content
. 2020 Jan 29;12(3):207–222. doi: 10.4155/fmc-2019-0063

Table 5. . MIC, IC50 and IC90 of compounds 2b, 5, 4f, 6c and 6f against Mtb resistant at different treatment and nontuberculous mycobacteria.

Compound INH-R1 INH-R2 RIF-R1 Mycobacterium avium
  MIC (μM) IC50 (μM) IC90 (μM) MIC (μM) IC50 (μM) IC90 (μM) MIC (μM) IC50 (μM) IC90 (μM) MIC (μM)
2b 98 68 90 28 24 28 111 60 160
5 >50 >50 >50 >50 >50 >50 >50 >50 >50
4f 55 46 52 65 39 75 67 35 100 >200
6c 120 42 170 110 42 150 87 24 110 >200
6f 24 13 21 25 13 22 25 15 24 200
C1 0.018 0.0084 0.022 0.065 0.0047 0.012 2 1.2 2.3 >200
C2 >200 >200 >200 >200 >200 >200 0.17 0.15 0.21
C3 1.2 0.64 1.4 1.4 0.84 1.4 0.76 0.59 0.91

Values indicate that compounds have a very good activity.

C1: Rifampicin control; C2: Isoniazid control; C3: Levofloxacin control; FQ: Fluoroquinolone resistant strain; IC50: 50% inhibition of growth; IC90: 90% inhibition of growth; INH: Isoniazid resistant strain; MIC: Minimum inhibitory concentration; RIF: Rifampicin resistant strain.